Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

23,772 signal articles · 346 in last 24h · 113,134 total before filter · latest 1h ago
346last 24h
2045last 7d
342● bullish (7d)
174● bearish (7d)
204publishers
AllMacro319Earnings1115M&A93Regulatory23Product17Analyst21
✕ clear all filtersticker: ^DJISentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Tesla Stock Dropped. Costs Are a Problem.
Barrons.com86d agobearish
Tesla Stock Dropped. Costs Are a Problem.

Investors didn’t seem to like Tesla raising prices of its popular Model Y vehicles in the U.S. over the weekend. Shares of the electric vehicle maker were down 0.7% at $406 in premarket trading on Tuesday, while and futures were down 0.2% and 0.1% respectively. There wasn’t much to blame the decline on, no Wall Street downgrades or material price target cuts.

Oppenheimer made a specific call on stock market's biggest names
TheStreet86d agoneutral
Oppenheimer made a specific call on stock market's biggest names

The seven stocks that carried the market for two years started 2026 by falling 16% in a single quarter. The group that defined the AI rally had become the market's biggest source of disappointment. Now one of Wall Street's firms thinks the narrative is about to flip again. And it is pointing to ...

Asian shares trade mixed and Kospi falls nearly 4% as oil prices keep swinging
Associated Press86d agoneutral
Asian shares trade mixed and Kospi falls nearly 4% as oil prices keep swinging

Asian shares were mixed Tuesday as uncertainty about what will happen with the Iran war roiled global markets. Japan's benchmark Nikkei 225 lost 0.6% in morning trading to 60,433.79, erasing initial gains after the government reported that the economy grew for the second straight quarter in January-March, mainly due to better than expected consumer spending. Shares in Samsung Electronics slipped 3.8% and SK Hynix fell 4%, tracking losses in tech shares overnight on Wall Street.

3 Dow Jones Stocks We Find Risky
StockStory86d agoneutral
3 Dow Jones Stocks We Find Risky

The Dow Jones (^DJI) is made up of 30 of the most established and influential companies in the market. But even blue-chip stocks can struggle - some are dealing with slowing growth, outdated business models, or increasing competition.

US stocks end mixed as tech stocks slide, Treasury yields climb
Reuters Videos86d agoneutralVIDEO
US stocks end mixed as tech stocks slide, Treasury yields climb

<body><p>STORY: Wall Street's main indexes ended mixed on Monday, with the Dow adding about a third of a percent, the S&P 500 little changed and the tech-heavy Nasdaq shedding half a percent.</p><p>Ongoing worries about the disruption of oil supplies, inflation and elevated borrowing costs weighed on stocks and pushed the 10-year Treasury yield earlier in the session to its highest level since February 2025.</p><p>Kevin Mahn is president and chief investment officer at Hennion & Walsh Asset Management.</p><p>“Investors continue to try and digest higher oil prices, which have led to higher gas prices and introduced even more inflationary pressures into the system. So each time we hear news that the impasse in the Strait of Hormuz may be coming to an end, you see the tailwind come into the market and stocks move higher. On the flip side, each time we learn that that Strait of Hormuz is going to be locked, or at least blocked for a longer period of time, investors then get concerned, bond yields shoot up and the prospects for a rate hike as opposed to a rate cut get brought back on to the table."</p><p>The Nasdaq fell for a second consecutive session as investors&nbsp;took a break from the AI-driven rally that started in late March.</p><p>Seagate Technology fell almost 7%, while peer Micron shed 6%. Shares of Sandisk dropped more than 5% and Western Digital lost nearly 5%.&nbsp;</p><p>:: Nvidia</p><p>The world's most valuable company, Nvidia, also closed lower, ahead of its scheduled quarterly earnings report later this week.</p><p>:: Archive</p><p>Elsewhere in the market, shares of Regeneron tumbled almost 10% as the drugmaker's experimental treatment for melanoma missed the main goal in a late-stage trial.</p></body>